Alopecia treatment sales will grow through 2035, led by topical drugs at 33.7% share of the therapy segment in 2025. Retail pharmacies hold 27.8% share of the sales channel segment in 2025. The market is expected to reach USD 12.5 billion in 2025 and USD 30.5 billion by 2035.